Allogene Therapeutics ALLO
NASDAQ ALLO
$1.25 -0.09 (-6.39%)
As of: Oct 22, 2026 · 2:25 PM EDT

Allogene Therapeutics (ALLO) EBIT (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) posted EBIT of -$46.92 million for Q2 2026, compared with -$56.82 million a year earlier.

Analysis

Allogene Therapeutics (ALLO) EBIT (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Allogene Therapeutics was -$180.32 million; for FY2025, it was -$209.32 million.

  • In prior years, Allogene Therapeutics' EBIT was -$273.2 million in FY2024, -$327.74 million in FY2023, -$335.54 million in FY2022 and -$180.19 million in FY2021.
  • Quarterly EBIT has run from a low of -$99.09 million in Q1 2023 to a high of $1.71 million in Q4 2021 over five years.
  • According to Business Quant data, EBIT for the three prior quarters was -$46.09 million (Q1 2026), -$42.4 million (Q4 2025) and -$44.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn 6.43 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn 3.16 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 4.27 Bn
10 Allogene Therapeutics 409.52 Mn -692.38 Mn - -46.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.92 Mn
Mar 31, 2026 -46.09 Mn
Dec 31, 2025 -42.40 Mn
Sep 30, 2025 -44.90 Mn
Jun 30, 2025 -56.82 Mn
Mar 31, 2025 -65.19 Mn
Dec 31, 2024 -60.49 Mn
Sep 30, 2024 -71.77 Mn
Jun 30, 2024 -71.43 Mn
Mar 31, 2024 -69.50 Mn
Dec 31, 2023 -85.11 Mn
Sep 30, 2023 -63.00 Mn
Jun 30, 2023 -80.54 Mn
Mar 31, 2023 -99.09 Mn
Dec 31, 2022 -96.40 Mn
Sep 30, 2022 -82.51 Mn
Jun 30, 2022 -76.62 Mn
Mar 31, 2022 -80.01 Mn
Dec 31, 2021 1.71 Mn
Sep 30, 2021 -77.67 Mn
API Access

Allogene Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ALLO&period=max&api_key=YOUR_API_KEY